India’s Implant Market to Reach USD 5 Billion by FY28 on Strong DemandIndia's orthopaedic and cardiac implant industry is likely to grow to USD 4.5–5 billion by FY2027-28, almost twice the size it is today at USD 2.4–2.7 billion in FY24...
US President Donald Trump’s new price range for Rx drugs with other developed countries might not affect the generic companies in India.
JB Pharma is making significant strides in the fight against hypertension and its impact on kidney health, in India. On the occasion of the upcoming ‘World Hypertension Day’ celebrated on 17th May
The net profit of Glaxosmithkline pharmaceuticals has been raised to 34.73 percent in the quarter of March 2025.
U.S. President Donald Trump’s latest administrative order pointing to cut domestic drug prices could wave across global pharmaceutical markets, with certain pressure on India to raise prices.
India’s pharmaceutical sector is feeling the heat after U.S. President Donald Trump unveiled a bold plan to cut drug prices by 30-80%. This policy, aimed at making U.S. drug costs match lower prices in other countries, could shake up the 9 billio...
During a massive crackdown across Telangana, Drug Control Administration (DCA) officials raided 66 pharmacies linked to corporate hospitals; they found a mass violation of regulations including sale of...
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL...
The National Pharmaceutical Pricing Authority (NPPA) has set 84 drug formulations' retail prices, including 36 formulations of empagliflozin, a diabetes drug that was originally developed by German firm Boehringer Ingelheim...
A significant attempt to stop illegal sale of narcotic and psychotropic drugs has been made by the Gujarat Food and Drugs Control Administration (FDCA) in a major crackdown effort on the illicit sale of drugs in the state...
, CDSCO.jpg)